Amoneta Diagnostics - Amoneta DiagnosticsAmoneta DiagnosticsAmoneta Diagnostics

  • Products
    • APO-Easy®
    • NeuroDeGene®
    • MemoryLinc®
    • NeuroLINCs
  • Projects
  • About Us
  • News & Events
  • Contact Us

Tag: Business

Amoneta Diagnostics > News & Events > Business
Posted on November 6, 2023March 7, 2024 Tags Business, Innovation

Amoneta Diagnostics joins Pépinière d’Entreprises Innovantes pH8

Amoneta Diagnostics announces that it has become a member of the Pépinière d'entreprises innovantes pH8, the region's premier business incubator focusing on healthcare and new technologies.
Read More

Tags

Business Conference Innovation Medical Neurology Products

Recent Posts

  • Amoneta Diagnostics at AD/PD™ 2025: APO-Easy® Genotyping kit in the Context of New Therapies’ LaunchMarch 27, 2025
  • “Meet&Match” BiovalleyOur CEO speaks on Gender and Genetics at “Meet&Match” event in StrasbourgDecember 9, 2024
Empowering clinicians, healthcare professionals, and drug developers with innovative biomarkers for precise characterization of patients with neurodegenerative disorders.
Contact us
Know more about us

Products

  • APO-Easy®
  • NeuroDeGene®
  • MemoryLinc®
  • NeuroLINCs

useful links

  • Products
  • Projects
  • About Us
  • News & Events
  • Contact Us
  • Instructions for Use

RECENT POSTS

  • Amoneta Diagnostics at AD/PD™ 2025: APO-Easy® Genotyping kit in the Context of New Therapies’ LaunchMarch 27, 2025
  • “Meet&Match” BiovalleyOur CEO speaks on Gender and Genetics at “Meet&Match” event in StrasbourgDecember 9, 2024
Copyright © 2025 Amoneta Diagnostics. All rights reserved.